362 related articles for article (PubMed ID: 7865431)
1. Taxol (paclitaxel): mechanisms of action.
Horwitz SB
Ann Oncol; 1994; 5 Suppl 6():S3-6. PubMed ID: 7865431
[TBL] [Abstract][Full Text] [Related]
2. Direct photoaffinity labeling of tubulin with taxol.
Rao S; Horwitz SB; Ringel I
J Natl Cancer Inst; 1992 May; 84(10):785-8. PubMed ID: 1349352
[TBL] [Abstract][Full Text] [Related]
3. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
[TBL] [Abstract][Full Text] [Related]
4. [Microtubules and antineoplastic drugs].
Arioka H; Saijo N
Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790
[TBL] [Abstract][Full Text] [Related]
5. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
6. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
7. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
8. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
9. GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol.
Shintani Y; Tanaka T; Nozaki Y
Cancer Chemother Pharmacol; 1997; 40(6):513-20. PubMed ID: 9332466
[TBL] [Abstract][Full Text] [Related]
10. Insights into the mechanism of microtubule stabilization by Taxol.
Xiao H; Verdier-Pinard P; Fernandez-Fuentes N; Burd B; Angeletti R; Fiser A; Horwitz SB; Orr GA
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10166-10173. PubMed ID: 16801540
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J
J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536
[TBL] [Abstract][Full Text] [Related]
12. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
13. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
14. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
[TBL] [Abstract][Full Text] [Related]
15. How does taxol stabilize microtubules?
Arnal I; Wade RH
Curr Biol; 1995 Aug; 5(8):900-8. PubMed ID: 7583148
[TBL] [Abstract][Full Text] [Related]
16. Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel.
Nakamura M; Nakazawa J; Usui T; Osada H; Kono Y; Takatsuki A
Biosci Biotechnol Biochem; 2003 Jan; 67(1):151-7. PubMed ID: 12619686
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
18. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M
Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858
[TBL] [Abstract][Full Text] [Related]
19. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action.
Abal M; Andreu JM; Barasoain I
Curr Cancer Drug Targets; 2003 Jun; 3(3):193-203. PubMed ID: 12769688
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
